Is there any correlation between liver graft regeneration and recipient's pretransplant skeletal muscle mass?-a study in extended left lobe graft living-donor liver transplantation.

Liver regeneration living-donor liver transplantation (LDLT) malnutrition sarcopenia skeletal muscle mass index

Journal

Hepatobiliary surgery and nutrition
ISSN: 2304-3881
Titre abrégé: Hepatobiliary Surg Nutr
Pays: China (Republic : 1949- )
ID NLM: 101600750

Informations de publication

Date de publication:
Apr 2020
Historique:
entrez: 2 5 2020
pubmed: 2 5 2020
medline: 2 5 2020
Statut: ppublish

Résumé

The end-stage liver disease causes a metabolic dysfunction whose most prominent clinical feature is the loss of skeletal muscle mass (SMM). In living-donor liver transplantation (LDLT), liver graft regeneration (GR) represents a crucial process to normalize the portal hypertension and to meet the metabolic demand of the recipient. Limited data are available on the correlation between pre-LDLT low SMM and GR. Retrospective study on a cohort of 106 LDLT patients receiving an extended left liver lobe graft. The skeletal muscle index (SMI) at L3 level was used for muscle mass measurement, and the recommended cut-off values of the Japanese Society of Hepatology guidelines were used as criteria for defining low muscularity. GR was evaluated as rate of volume increase at 1 month post-LT [graft regeneration rate (GRR)]. The median GRR at 1 month post-LT was 91% (IQR, 65-128%) and a significant correlation with graft volume-to-recipient standard liver volume ratio (GV/SLV) (rho -0.467, P<0.001), graft-to-recipient weight ratio (GRWR) (rho -0.414, P<0.001), donor age (rho -0.306, P=0.001), 1 month post-LT cholinesterase serum levels (rho 0.397, P=0.002) and pre-LT low muscularity [absent Additionally to the hemodynamic factors of portal circulation and the quality of the graft, the metabolic status of the recipients has a significant role in the GR process. A pre-LT low SMM is associated with impaired GRR and this negative impact is more evident in male recipients.

Sections du résumé

BACKGROUND BACKGROUND
The end-stage liver disease causes a metabolic dysfunction whose most prominent clinical feature is the loss of skeletal muscle mass (SMM). In living-donor liver transplantation (LDLT), liver graft regeneration (GR) represents a crucial process to normalize the portal hypertension and to meet the metabolic demand of the recipient. Limited data are available on the correlation between pre-LDLT low SMM and GR.
METHODS METHODS
Retrospective study on a cohort of 106 LDLT patients receiving an extended left liver lobe graft. The skeletal muscle index (SMI) at L3 level was used for muscle mass measurement, and the recommended cut-off values of the Japanese Society of Hepatology guidelines were used as criteria for defining low muscularity. GR was evaluated as rate of volume increase at 1 month post-LT [graft regeneration rate (GRR)].
RESULTS RESULTS
The median GRR at 1 month post-LT was 91% (IQR, 65-128%) and a significant correlation with graft volume-to-recipient standard liver volume ratio (GV/SLV) (rho -0.467, P<0.001), graft-to-recipient weight ratio (GRWR) (rho -0.414, P<0.001), donor age (rho -0.306, P=0.001), 1 month post-LT cholinesterase serum levels (rho 0.397, P=0.002) and pre-LT low muscularity [absent
CONCLUSIONS CONCLUSIONS
Additionally to the hemodynamic factors of portal circulation and the quality of the graft, the metabolic status of the recipients has a significant role in the GR process. A pre-LT low SMM is associated with impaired GRR and this negative impact is more evident in male recipients.

Identifiants

pubmed: 32355676
doi: 10.21037/hbsn.2019.11.08
pii: hbsn-09-02-183
pmc: PMC7188548
doi:

Types de publication

Journal Article

Langues

eng

Pagination

183-194

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

2020 Hepatobiliary Surgery and Nutrition. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.11.08). The authors have no conflicts of interest to declare.

Références

World J Gastroenterol. 2016 Jun 7;22(21):4966-76
pubmed: 27275089
Surg Today. 2015 Jun;45(6):663-71
pubmed: 24894564
J Gastroenterol Hepatol. 2015 Jul;30(7):1217-24
pubmed: 25682855
Dig Dis Sci. 2013 Nov;58(11):3103-11
pubmed: 23912247
Nutrients. 2018 Dec 18;10(12):
pubmed: 30567387
Am J Transplant. 2014 Dec;14(12):2777-87
pubmed: 25395154
Liver Transpl. 2015 Jan;21(1):79-88
pubmed: 25065488
Liver Transpl. 2016 Nov;22(11):1519-1525
pubmed: 27342832
World J Surg. 2012 May;36(5):1102-11
pubmed: 22374540
Aliment Pharmacol Ther. 2016 Apr;43(7):765-77
pubmed: 26847265
J Gastroenterol Hepatol. 2015 Feb;30(2):244-51
pubmed: 25087838
Liver Transpl. 2003 Jun;9(6):547-51
pubmed: 12783393
Liver Transpl. 2017 Nov;23(11):1451-1464
pubmed: 29072825
Curr Gerontol Geriatr Res. 2011;2011:526379
pubmed: 21912543
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):113-121
pubmed: 27239424
Liver Transpl. 2016 Jan;22(1):103-10
pubmed: 26202132
Ann Transplant. 2018 Jul 27;23:507-519
pubmed: 30050031
Hepatol Res. 2016 Sep;46(10):951-63
pubmed: 27481650
Am J Transplant. 2009 Jun;9(6):1382-8
pubmed: 19459827
Ann Transplant. 2018 Jul 17;23:481-490
pubmed: 30013021
Clin Transplant. 2019 Apr;33(4):e13495
pubmed: 30773726
Liver Transpl. 2009 Sep;15(9):1043-9
pubmed: 19718645
Medicine (Baltimore). 2016 Nov;95(46):e5404
pubmed: 27861381
Transplantation. 2000 Dec 27;70(12):1703-7
pubmed: 11152100
Clin Imaging. 2008 Jan-Feb;32(1):6-10
pubmed: 18164387

Auteurs

Riccardo Pravisani (R)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Akihiko Soyama (A)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Shinichiro Ono (S)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Umberto Baccarani (U)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Miriam Isola (M)

Division of Medical Statistic, Department of Medicine, University of Udine, Udine, Italy.

Mitsuhisa Takatsuki (M)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Masaaki Hidaka (M)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Tomohiko Adachi (T)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Takanobu Hara (T)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Takashi Hamada (T)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Florian Pecquenard (F)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Andrea Risaliti (A)

Liver-Kidney Transplant Unit, Department of Medicine, University of Udine, Udine, Italy.

Susumu Eguchi (S)

Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Classifications MeSH